Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

S. Wade Kimmell, OD

Advertisement

Articles by S. Wade Kimmell, OD

S. Wade Kimmell, OD on the importance of updated Glaucoma, OSD and dry eye treatments

ByS. Wade Kimmell, OD
January 30th 2020

Your glaucoma patients also have ocular surface disease

ByS. Wade Kimmell, OD
January 29th 2020

Employ treatment strategies that control both conditions with less reliance on drops.

Advertisement

Latest Updated Articles

  • Your glaucoma patients also have ocular surface disease
    Your glaucoma patients also have ocular surface disease

    Published: January 29th 2020 | Updated:

  • S. Wade Kimmell, OD on the importance of updated Glaucoma, OSD and dry eye treatments
    S. Wade Kimmell, OD on the importance of updated Glaucoma, OSD and dry eye treatments

    Published: January 30th 2020 | Updated:



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

FDA approves Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for presbyopia

2

MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension

3

Study finds artificial tear viscosity and shear-thinning behavior vary by formulation

4

FDA clears Novaliq’s Investigational New Drug application for NOV05

5

FDA approves NDA labeling supplement allowing re-administration of iDose TR

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us